NTII — Neurobiological Technologies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.25m
- $26.35m
Annual cashflow statement for Neurobiological Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
C2005 June 30th | C2006 June 30th | C2007 June 30th | 2008 June 30th | 2009 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25 | -27.8 | -14.1 | -16.3 | 3.12 |
| Depreciation | |||||
| Non-Cash Items | 12.7 | 12.3 | -0.022 | 1.74 | 1.93 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.82 | 24.3 | 0.79 | -6.32 | -21.6 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -9.41 | 8.98 | -13.1 | -20.7 | -16.4 |
| Other Investing Cash Flow Items | 7.52 | -0.175 | 2.07 | -11.8 | -3.28 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 7.52 | -0.175 | 2.07 | -11.8 | -3.28 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.703 | 0.106 | 6.86 | 54.9 | 0.001 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.18 | 8.91 | -4.2 | 22.4 | -19.7 |